Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.16 USD | -0.32% | +1.28% | +11.27% |
09/05 | Transcript : DiaMedica Therapeutics Inc., Q1 2024 Earnings Call, May 09, 2024 | |
17/04 | DiaMedica Therapeutics Launches Late-Stage Trial of Potential Stroke Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.27% | 120M | |
+8.66% | 114B | |
+10.74% | 104B | |
-12.78% | 22.41B | |
-0.99% | 22.28B | |
-5.71% | 19.07B | |
-37.36% | 18B | |
-5.36% | 17.89B | |
+7.43% | 14.28B | |
+36.30% | 12.55B |
- Stock Market
- Equities
- DMAC Stock
- News DiaMedica Therapeutics Inc.
- DiaMedica Therapeutics : Maxim Group Adjusts Price Target on DiaMedica Therapeutics to $11 From $14, Reiterates Buy Rating